Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Badawy, A. A.-B.
Right arrow Articles by Farmer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Badawy, A. A.-B.
Right arrow Articles by Farmer, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 19, No. 4, 385-391 (2005)
DOI: 10.1177/0269881105053293

Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome

Abdulla A.-B. Badawy

Cardiff & Vale NHS Trust, Biomedical Research Laboratory, Whitchurch Hospital, Cardiff, Wales, UK., Abdulla.Badawy{at}cardiffandvale.wales.nhs.uk

Christopher J. Morgan

Cardiff & Vale NHS Trust, Biomedical Research Laboratory, Whitchurch Hospital, Cardiff, Wales, UK.

Meirion B. Llewelyn

Department of Medicine, Royal Gwent Hospital, Newport, Gwent, Wales, UK.

Selwyn R.J. Albuquerque

Division of Psychological Medicine, University of Wales College of Medicine, Cardiff, Wales, UK.

Anne Farmer

Division of Psychological Medicine, University of Wales College of Medicine, Cardiff, Wales, UK.

We assessed the serotonin status of patients with the chronic fatigue syndrome (CFS). Tryptophan (Trp) availability to the brain, expressed as the ratio of concentration of serum Trp to the sum of those of its five competitors (CAA), and other parameters of Trp disposition were compared in 23 patients with the CFS and 42 healthy controls. The serum [free Trp]/[CAA] ratio was 43% higher in CFS patients, due to a 48% higher [free Trp]. [Total Trp] was also significantly higher (by 19%) in CFS patients, and, although the [total Trp]/[CAA] ratio did not differ significantly between the control and patient groups, the difference became significant when the results were co-varied with age and gender. [CAA] was not significantly different between groups, but was significantly lower in females, compared to males, of the CFS patient group. We have established normal ranges for Trp disposition parameters and propose criteria for defining the serotonin-biosynthetic status in humans. We have provisionally identified two subgroups of CFS patients, one with normal serotonin and the other with a high serotonin status. The relevance of our findings to, and their implications for, the pharmacological and other therapies of the chronic fatigue syndrome are discussed.

Key Words: amino acids • chronic fatigue syndrome • selective serotonin re-uptake inhibitors • serotonin function • tryptophan • tryptophan availability to the brain


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin RehabilHome page
B. Van Houdenhove, L. Verheyen, K. Pardaens, P. Luyten, and P. Van Wambeke
Rehabilitation of decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance?
Clinical Rehabilitation, December 1, 2007; 21(12): 1121 - 1142.
[Abstract] [PDF]


Home page
The OncologistHome page
J. L. Ryan, J. K. Carroll, E. P. Ryan, K. M. Mustian, K. Fiscella, and G. R. Morrow
Mechanisms of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 22 - 34.
[Abstract] [Full Text] [PDF]